- Pharmaceutical and Medicine Manufacturing (NAICS 3254); Medical and Diagnostic Laboratories (NAICS 62151)
- Healthcare Service (NAICS 621); Hospitals (NAICS 622)
We develop and provide blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. We offer products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Our products include automated blood collection systems, information systems, data collection systems, apheresis systems, cell processors, cell separation systems, pathogen reduction technology systems, whole blood processing systems, cell expansion systems, sterile tubing welders, blood bags, tube sealing devices. We employ more than 6,000 associates with our global headquarters in Lakewood, CO, U.S., and regional headquarters in Brussels, Buenos Aires, Singapore and Tokyo.
Whom to Contact
- Mr. Florian DeichmannPlant Manager/GD
- Mr. Neil MurphyChairman, Global TBCT VP Manufacturing (Eastern Hemisphere)